Go offline with the Player FM app!
Podcasts Worth a Listen
SPONSORED


1 Sweat and Resilience: Balancing Chronic Migraine with Fitness Goals 35:02
Trillion Dollar Shot, Episode 1: Birth of a Blockbuster
Manage episode 417983010 series 2518362
Before Ozempic, Wegovy, Mounjaro and Zepbound, there was Lotte Bjerre Knudsen.
In the 1990s, the young scientist at the Danish drug company Novo Nordisk was trying to unlock the key to a new technology for treating Type 2 diabetes. To her bosses, Lotte’s project, which focused on a hormone called GLP-1, looked like a distraction.
But as Lotte fought to save her diabetes project from the chopping block, she couldn’t have imagined how much of an impact her breakthrough would have. Her work would pave the way for a hit drug called Ozempic. And it would unleash a new class of blockbuster drugs, pitting two companies in a race to become the world’s first trillion-dollar pharmaceutical company by market cap.
Listen to Part 1 of “Trillion Dollar Shot” now.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1506 episodes
Manage episode 417983010 series 2518362
Before Ozempic, Wegovy, Mounjaro and Zepbound, there was Lotte Bjerre Knudsen.
In the 1990s, the young scientist at the Danish drug company Novo Nordisk was trying to unlock the key to a new technology for treating Type 2 diabetes. To her bosses, Lotte’s project, which focused on a hormone called GLP-1, looked like a distraction.
But as Lotte fought to save her diabetes project from the chopping block, she couldn’t have imagined how much of an impact her breakthrough would have. Her work would pave the way for a hit drug called Ozempic. And it would unleash a new class of blockbuster drugs, pitting two companies in a race to become the world’s first trillion-dollar pharmaceutical company by market cap.
Listen to Part 1 of “Trillion Dollar Shot” now.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1506 episodes
All episodes
×

1 Lady Gaga, Low-Rise Jeans, and the Next Recession 20:17


1 Eggs Are Still Expensive. Is This Company to Blame? 19:11


1 Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out? 19:42


1 Can the GOP Unite Around Trump’s ‘Big, Beautiful Bill’? 19:06






1 An Air Traffic Controller Speaks Out About Newark Airport 20:43










1 Made in America? Shoe Companies Already Tried That. 18:02




Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.